KKR to sell minority stake in Nordic Bioscience to company founder
Thursday, September 3, 2026 · first reported by PE Hub
KKR divests minority stake in Nordic Bioscience to company founder; investment doubled company revenue across R&D, diagnostics, and drug development.
- Firm
- KKR
- Also named
- Nordic Bioscience
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on KKR
Everything on this firm →- Samsung pledges $1b to KKR’s Helix Digital Infrastructure to support AI infrastructure buildoutIREI
- KKR completes majority stake deal for Thomson Reuters’ print businessPE Hub
- KKR agrees majority investment in Indian liquid storage platform CisterninaPE Hub
- KKR holds first close for real estate fundPERE
- KKR launches $350m equipment finance platformAlternative Credit Investor +1
- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets